About 400 reports

HIV/ AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV ##/ ##, Combo, Ag, NAT, Western Blot----Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts I.

  • HIV AIDS
  • Infectious Disease
  • Pathology
  • World
  • Demand

2016-2020 Future Horizons and Growth Strategies in the World HIV/ AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities I.

  • Health Services
  • HIV AIDS
  • Pathology
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

HIV/ AIDS Diagnostics Market: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers I.

  • HIV AIDS
  • Europe
  • Japan
  • United States
  • Demand

HIV/ AIDS: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers I Introduction II AIDS/ HIV Worldwide Market and Technology Overview A Background B Diagnostic Tests: HIV-

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand
  • Identifying factors impacting market growth
  • OTHERS

About Antiretroviral Therapy The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART...

  • Cultural Attraction
  • HIV AIDS
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand
  • 7.4.8 HIV/AIDS
  • In-vitro Diagnostics Market: Revenue in USD billion, by Application, HIV/AIDS, United States, 2018-2023

The US in-vitro diagnostics market has been estimated at USD 13.57 billion in 2017 and is expected to register a CAGR of 5.57% during the forecast period, 2018 to 2023. Due to increasing incidences of chronic diseases and rapid adoption of point-of-care testing, along with increasing preference for personalized medicine, the in-vitro diagnostics...

  • HIV AIDS
  • North America
  • United States
  • Becton Property Group
  • Bio-Rad Laboratories, Inc.

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand